BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23032699)

  • 1. Suppression of PRMT6-mediated arginine methylation of p16 protein potentiates its ability to arrest A549 cell proliferation.
    Wang X; Huang Y; Zhao J; Zhang Y; Lu J; Huang B
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2333-41. PubMed ID: 23032699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine methylation of the human immunodeficiency virus type 1 Tat protein by PRMT6 negatively affects Tat Interactions with both cyclin T1 and the Tat transactivation region.
    Xie B; Invernizzi CF; Richard S; Wainberg MA
    J Virol; 2007 Apr; 81(8):4226-34. PubMed ID: 17267505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of phosphorylation and methylation on the function of the p16
    Ma WL; Wang L; Liu LX; Wang XL
    Oncol Lett; 2015 Oct; 10(4):2277-2282. PubMed ID: 26622834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interplay between p16 serine phosphorylation and arginine methylation determines its function in modulating cellular apoptosis and senescence.
    Lu Y; Ma W; Li Z; Lu J; Wang X
    Sci Rep; 2017 Jan; 7():41390. PubMed ID: 28120917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The arginine methyltransferase PRMT6 regulates cell proliferation and senescence through transcriptional repression of tumor suppressor genes.
    Stein C; Riedl S; Rüthnick D; Nötzold RR; Bauer UM
    Nucleic Acids Res; 2012 Oct; 40(19):9522-33. PubMed ID: 22904088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric dimethylation of AMPKα1 by PRMT6 contributes to the formation of phase-separated puncta.
    Yoo YJ; Cho G; Kim D; Kim Y; Yun N; Oh YJ
    Biochem Biophys Res Commun; 2023 Jul; 666():92-100. PubMed ID: 37178510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pUL69 of Human Cytomegalovirus Recruits the Cellular Protein Arginine Methyltransferase 6 via a Domain That Is Crucial for mRNA Export and Efficient Viral Replication.
    Thomas M; Sonntag E; Müller R; Schmidt S; Zielke B; Fossen T; Stamminger T
    J Virol; 2015 Sep; 89(18):9601-15. PubMed ID: 26178996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRMT6 diminishes HIV-1 Rev binding to and export of viral RNA.
    Invernizzi CF; Xie B; Richard S; Wainberg MA
    Retrovirology; 2006 Dec; 3():93. PubMed ID: 17176473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automethylation of protein arginine methyltransferase 6 (PRMT6) regulates its stability and its anti-HIV-1 activity.
    Singhroy DN; Mesplède T; Sabbah A; Quashie PK; Falgueyret JP; Wainberg MA
    Retrovirology; 2013 Jul; 10():73. PubMed ID: 23866860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis of arginine asymmetrical dimethylation by PRMT6.
    Wu H; Zheng W; Eram MS; Vhuiyan M; Dong A; Zeng H; He H; Brown P; Frankel A; Vedadi M; Luo M; Min J
    Biochem J; 2016 Oct; 473(19):3049-63. PubMed ID: 27480107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle regulation by the PRMT6 arginine methyltransferase through repression of cyclin-dependent kinase inhibitors.
    Kleinschmidt MA; de Graaf P; van Teeffelen HA; Timmers HT
    PLoS One; 2012; 7(8):e41446. PubMed ID: 22916108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRMT6 Regulates RAS/RAF Binding and MEK/ERK-Mediated Cancer Stemness Activities in Hepatocellular Carcinoma through CRAF Methylation.
    Chan LH; Zhou L; Ng KY; Wong TL; Lee TK; Sharma R; Loong JH; Ching YP; Yuan YF; Xie D; Lo CM; Man K; Artegiani B; Clevers H; Yan HH; Leung SY; Richard S; Guan XY; Huen MSY; Ma S
    Cell Rep; 2018 Oct; 25(3):690-701.e8. PubMed ID: 30332648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation of Tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression.
    Boulanger MC; Liang C; Russell RS; Lin R; Bedford MT; Wainberg MA; Richard S
    J Virol; 2005 Jan; 79(1):124-31. PubMed ID: 15596808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein arginine methyltransferase 6 enhances ligand-dependent and -independent activity of estrogen receptor α via distinct mechanisms.
    Sun Y; Chung HH; Woo AR; Lin VC
    Biochim Biophys Acta; 2014 Sep; 1843(9):2067-78. PubMed ID: 24742914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fate of pancreatic tumor cell lines following p16 overexpression depends on the modulation of CDK2 activity.
    Calbó J; Serna C; Garriga J; Graña X; Mazo A
    Cell Death Differ; 2004 Oct; 11(10):1055-65. PubMed ID: 15309028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.
    Fåhraeus R; Laín S; Ball KL; Lane DP
    Oncogene; 1998 Feb; 16(5):587-96. PubMed ID: 9482104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganoderma lucidum polysaccharide inhibits prostate cancer cell migration via the protein arginine methyltransferase 6 signaling pathway.
    Zhao X; Zhou D; Liu Y; Li C; Zhao X; Li Y; Li W
    Mol Med Rep; 2018 Jan; 17(1):147-157. PubMed ID: 29115463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of post-translational protein arginine methylation during HeLa cell cycle.
    Kim C; Lim Y; Yoo BC; Won NH; Kim S; Kim G
    Biochim Biophys Acta; 2010 Sep; 1800(9):977-85. PubMed ID: 20541591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissection of CDK4-binding and transactivation activities of p34(SEI-1) and comparison between functions of p34(SEI-1) and p16(INK4A).
    Li J; Muscarella P; Joo SH; Knobloch TJ; Melvin WS; Weghorst CM; Tsai MD
    Biochemistry; 2005 Oct; 44(40):13246-56. PubMed ID: 16201750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G1 arrest by p16INK4A uncouples growth from cell cycle progression in leukemia cells with deregulated cyclin E and c-Myc expression.
    Ausserlechner MJ; Obexer P; Geley S; Kofler R
    Leukemia; 2005 Jun; 19(6):1051-7. PubMed ID: 15800668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.